ConductScience.org, home

Paper23314745

Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.

Domagalski K and 7 others. Eur J Clin Microbiol Infect Dis, 2013. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4. Papers, record 23314745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23314745

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
PubMed
Journal
Eur J Clin Microbiol Infect Dis
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2026-01-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Domagalski KK
2Pawłowska MM
3Tretyn AA
4Halota WW
5Pilarczyk MM
6Smukalska EE
7Linkowska KK
8Grzybowski TT

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GenotypeMajor topic
HepacivirusMajor topic
Hepatitis C, ChronicMajor topic
Interferon-alphaMajor topic
InterleukinsMajor topic
Polyethylene GlycolsMajor topic
Polymorphism, Single NucleotideMajor topic
RibavirinMajor topic
Adolescent
Antiviral Agents
Child
Child, Preschool
Drug Therapy, Combination
Female
Humans
Interferons
Male
Recombinant Proteins
Treatment Outcome
Viral Load
Interferon Lambda

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120136589Treatment of hepatitis C in children.Expert Rev Gastroenterol Hepatol2010https://conductscience.org/library/papers/20136589PubMed
222013729Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child?Eur Rev Med Pharmacol Sci2011https://conductscience.org/library/papers/22013729PubMed
319904504Pegylated alpha interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection.Indian J Pediatr2009https://conductscience.org/library/papers/19904504PubMed
419749758IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.Nat Genet2009https://conductscience.org/library/papers/19749758PubMed
520189674High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.J Hepatol2010https://conductscience.org/library/papers/20189674PubMed
620728570Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.Clin Gastroenterol Hepatol2011https://conductscience.org/library/papers/20728570PubMed
719840256Current issues in the management of paediatric viral hepatitis.Liver Int2010https://conductscience.org/library/papers/19840256PubMed
818925643Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.Hepatology2008https://conductscience.org/library/papers/18925643PubMed
920060832Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.Gastroenterology2010https://conductscience.org/library/papers/20060832PubMed
1020176026Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.Gastroenterology2010https://conductscience.org/library/papers/20176026PubMed
1119749757Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.Nat Genet2009https://conductscience.org/library/papers/19749757PubMed
1218174875Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.Pediatr Infect Dis J2008https://conductscience.org/library/papers/18174875PubMed
1319756352Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.J Gastroenterol2009https://conductscience.org/library/papers/19756352PubMed
1418715665Treatment predictors of a sustained virologic response in hepatitis B and C.J Hepatol2008https://conductscience.org/library/papers/18715665PubMed
1521413051Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children.Hepatology2011https://conductscience.org/library/papers/21413051PubMed
1619684573Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.Nature2009https://conductscience.org/library/papers/19684573PubMed
1720633102Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Liver Int2010https://conductscience.org/library/papers/20633102PubMed
1820526008Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents.Ann Hepatol2010https://conductscience.org/library/papers/20526008PubMed
1915793840Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.Hepatology2005https://conductscience.org/library/papers/15793840PubMed
2019625712Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.N Engl J Med2009https://conductscience.org/library/papers/19625712PubMed

See all 26 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
30987134Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?Cells2019https://conductscience.org/library/papers/30987134PubMed
29238510Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.Electron Physician2017https://conductscience.org/library/papers/29238510PubMed
28507928The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.J Clin Transl Hepatol2017https://conductscience.org/library/papers/28507928PubMed
28502443Hepatitis B and C.Pediatr Clin North Am2017https://conductscience.org/library/papers/28502443PubMed
26640716Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?Int J Hepatol2015https://conductscience.org/library/papers/26640716PubMed
26478670What's new in hepatitis C virus infections in children?World J Gastroenterol2015https://conductscience.org/library/papers/26478670PubMed
25473150New treatments for chronic hepatitis C: an overview for paediatricians.World J Gastroenterol2014https://conductscience.org/library/papers/25473150PubMed
25071317Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.World J Gastroenterol2014https://conductscience.org/library/papers/25071317PubMed
24348648Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.Hepat Mon2013https://conductscience.org/library/papers/24348648PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNL3282617PubTator's text mininghttps://conductscience.org/library/genes/282617NCBI Gene
LOC102724197102724197PubTator's text mininghttps://conductscience.org/library/genes/102724197NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23314745

GET https://conductscience.org/api/papers/v1/23314745/references?page=2